NEEMA Published Papers - Tuberculosis
Menzies NA, Swartwood N, Testa C, Malyuta Y, Hill AN, Marks SM, Cohen T, Salomon JA. Time since infection and risk of future disease for individuals with latent TB infection in the United States. Epidemiology. 2020. In press
Shrestha S, Parriott A, Menzies NA, Shete PB, Hill AN, Marks SM, Dowdy DW. Estimated Population-level Impact of Using a Six-Week Regimen of Daily Rifapentine to Treat Latent Tuberculosis Infection in the United Statesexternal icon. Annals of the American Thoracic Society. 2020 Sep 11(ja).
Marks SM, Dowdy DW, Menzies NA, Shete PB, Salomon JA, Parriott A, Shrestha S, Flood J, Hill AN. Policy implications of mathematical modeling of latent tuberculosis infection testing and treatment strategies to accelerate tuberculosis eliminationexternal icon. Public Health Reports. 2020 Jul;135(1_suppl):38S-43S.
Menzies NA, Bellerose M, Testa C, Swartwood N, Malyuta Y, Cohen T, Marks SM, Hill AN, Date AA, Maloney SA, Bowden SE. Impact of Effective Global Tuberculosis Control on Health and Economic Outcomes in the United Statesexternal icon. American Journal of Respiratory and Critical Care Medicine. 2020 Jul 9(ja).
Parriott A, Kahn JG, Ashki H, Readhead A, Barry PM, Goodell AJ, Flood J, Shete PB. Modeling the impact of recommendations for primary care–based screening for latent tuberculosis infection in Californiaexternal icon. Public Health Reports. 2020 Jul;135(1_suppl):172S-81S.
Jo Y, Shrestha S, Gomes I, Marks S, Hill A, Asay G, Dowdy D. Model-Based Cost-Effectiveness of State-level Latent Tuberculosis Interventions in California, Florida, New York and Texasexternal icon. Clinical Infectious Diseases. 2020 Jun 25.
Menzies NA, Parriott A, Shrestha S, Dowdy DW, Cohen T, Salomon JA, et al. Comparative modeling of tuberculosis epidemiology and policy outcomes in Californiaexternal icon. American Journal of Respiratory and Critical Care Medicine. 2020;201:356–365.
Miller AP, Malekinejad M, Horváth H, Blodgett JC, Kahn JG, Marks SM. Healthcare facility-based strategies to improve tuberculosis testing and linkage to care in non-US-born population in the United States: A systematic reviewexternal icon. PloS One. 2019;14(9).
Shrestha S, Cherng S, Hill AN, Reynolds S, Flood J, Barry PM, Readhead A, Oxtoby M, Lauzardo M, Privett T, Marks SM. Impact and Effectiveness of State-level Tuberculosis Interventions in California, Florida, New York and Texas: A Model-based Analysis.external icon American journal of epidemiology. 2019 Jun 28.
Goodell AJ, Shete PB, Vreman R, McCabe D, Porco TC, Barry PM, Flood J, Marks SM, Hill A, Cattamanchi A, Kahn JG. Outlook for Tuberculosis Elimination in California: An Individual-based Stochastic Modelexternal icon. PloS one. 2019 Apr 9;14(4):e0214532.
Menzies NA, Hill AN, Cohen T, Salomon JA. The impact of migration on tuberculosis in the United Statesexternal icon. The International Journal of Tuberculosis and Lung Disease. 2018 Dec 1;22(12):1392-403.
Cherng, S. T., Shrestha, S., Reynolds, S., Hill, A. N., Marks, S. M., Kelly, J., Dowdy, D. W. Tuberculosis Incidence Among Populations at High Risk in California, Florida, New York, and Texas, 2011–2015external icon, American Journal of Public Health 2018 Nov;108(S4):S311-4. Accessed 11/7/2018.
Parriott A, Malekinejad M, Miller AP, Horvath H, Marks SM, Kahn JG. Yield of Testing and Treatment for Tuberculosis Among Foreign-Born Persons During Contact Investigations in the United States: A Semi-Systematic Reviewexternal icon. PLoS ONE. 2018 Jul 19;13(7):e0200485.
Menzies NA, Cohen T, Hill AN, Yaesoubi R, Galer K, Wolf E, Marks SM, Salomon JA. Prospects for Tuberculosis Elimination in the United States: Results of a Transmission Dynamic Modelexternal icon. American Journal of Epidemiology. 2018 May 14;187(9):2011-20.
Parriott A, Malekinejad M, Miller AP, Marks SM, Horvath H, Kahn JG. Care Cascade for Targeted Tuberculosis Testing and Linkage to Care in Homeless Populations in the United States: a Meta-Analysisexternal icon. BMC Public Health. 2018 Apr 12;18(1):485. Accessed 5/18/2018.
Menzies NA, Wolf E, Connors D, Bellerose M, Sbarra AN, Cohen T, Hill AN, Yaesoubi R, Galer K, White PJ, Abubakar I, Salomon JA. Progression from Latent Infection to Active Disease in Dynamic Tuberculosis Transmission Models: a Systematic Review of the Validity of Modelling Assumptionsexternal icon. The Lancet Infectious Diseases. 2018 Apr 10. Accessed 5/18/2018.
Tasillo A, Salomon JA, Trikalinos TA, Horsburgh CR, Marks SM, Linas BP. Cost-effectiveness of Testing and Treatment for Latent Tuberculosis Infection in Residents Born Outside the United States With and Without Medical Comorbidities in a Simulation Modelexternal icon. JAMA Internal Medicine. 2017 Dec 1;177(12):1755-1764. Accessed 2/9/2018.
Malekinejad M, Parriott A, Viitanen AP, Horvath H, Marks SM, Kahn JG. Yield of Community-Based Tuberculosis Targeted Testing and Treatment in Foreign-Born Populations in the United States: A Systematic Reviewexternal icon. PloS one. 2017 Aug 7;12(8):e0180707.
Shrestha S, Hill AN, Marks SM, Dowdy DW. Comparing Drivers and Dynamics of Tuberculosis (TB) in California, Florida, New York and Texasexternal icon. American Journal of Respiratory And Critical Care Medicine. 2017 May 5(ja). Accessed 6/9/2017.